Skip to main content
Steven Osborne, MD, Internal Medicine, Silver Spring, MD

StevenFrancisOsborneMD

Internal Medicine Silver Spring, MD

Medical Officer / FDA

Dr. Osborne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Osborne's full profile

Already have an account?

  • Office

    10903 New Hampshire Avenue
    Silver Spring, MD 20904
    Phone+1 301-796-3604

Education & Training

  • Georgetown University Hospital
    Georgetown University Hospital1984 - 1986
  • Bethesda Naval Hospital
    Bethesda Naval Hospital1980 - 1981
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1980
  • University of Notre Dame
    University of Notre DameBS, Chemistry, 1970 - 1974
  • University of Notre Dame
    University of Notre DameB.S., Chemistry, 1970 - 1974

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1984 - 2019
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Time off Award for thorough assessment of safety and efficacy issues related to consumer antiseptics and thoughtful planning and execution of the October 20, 2005 NDAC meeting. NDAC, 2006
  • CDER Team Excellence Award: healthcare antiseptic drugs 2005
  • Time off Award for thorough assessment of safety and efficacy issues related to consumer antiseptics and thoughtful planning and execution 2005
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The Food and Drug Administration’s Drug Safety Oversight Board: An Evolving Paradigm for Clinical Input on Drug Safety Topics.  
    Grandinetti CA and Osborne SF, Clin Pharmacol Ther, 6/9/2010
  • Prevention of surgical-site infections.  
    Weiss KD, Osborne SF, Callahan-Lyon P, N Engl J Med., 4/1/2010
  • Perspectives on Early Communications of Drug Risks to the Public.  
    Seligman PJ and Osborne SF, Clin Pharmacol Ther, 3/1/2009
  • Join now to see all

Lectures

  • Coronary Artery Disease, Prevention, Detection and Treatment 
    Mayo Clinic, 2007, 2008, 2009, 2010 - 11/1/2012
  • FDA Drug Safety Oversight Board 
    Post-Approval Drug Safety Strategies Conference - 11/1/2010
  • Drug Safety Oversight Board 
    Regulatory Affairs Professional Society - 10/1/2010
  • Join now to see all